TW200501970A - Use of PVP-iodine liposomes for treatment of acne - Google Patents

Use of PVP-iodine liposomes for treatment of acne

Info

Publication number
TW200501970A
TW200501970A TW093103918A TW93103918A TW200501970A TW 200501970 A TW200501970 A TW 200501970A TW 093103918 A TW093103918 A TW 093103918A TW 93103918 A TW93103918 A TW 93103918A TW 200501970 A TW200501970 A TW 200501970A
Authority
TW
Taiwan
Prior art keywords
treatment
acne
pvp
iodine liposomes
liposomes
Prior art date
Application number
TW093103918A
Other languages
English (en)
Inventor
Karen Reimer
Wolfgang Fleischer
Michael Hopp
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of TW200501970A publication Critical patent/TW200501970A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093103918A 2003-02-24 2004-02-18 Use of PVP-iodine liposomes for treatment of acne TW200501970A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03003281A EP1449533A1 (en) 2003-02-24 2003-02-24 Use of PVP-iodine liposomes for the treatment of acne

Publications (1)

Publication Number Publication Date
TW200501970A true TW200501970A (en) 2005-01-16

Family

ID=32731522

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093103918A TW200501970A (en) 2003-02-24 2004-02-18 Use of PVP-iodine liposomes for treatment of acne

Country Status (11)

Country Link
US (2) US20060292244A1 (zh)
EP (2) EP1449533A1 (zh)
JP (1) JP2006518720A (zh)
AR (1) AR044201A1 (zh)
CY (1) CY1113959T1 (zh)
DK (1) DK1596876T3 (zh)
ES (1) ES2406455T3 (zh)
PT (1) PT1596876E (zh)
SI (1) SI1596876T1 (zh)
TW (1) TW200501970A (zh)
WO (1) WO2004073720A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1449520A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-Iodine liposomes for treatment of herpes
JP5388568B2 (ja) * 2005-03-30 2014-01-15 ルバンス セラピュティックス インク． ざ瘡を治療するための組成物及び方法
CA2864910C (en) * 2012-02-17 2018-07-24 Joseph CAPRIOTTI Antifungal compositions for the treatment of skin and nails
MX2017009450A (es) * 2015-01-20 2018-01-18 Veloce Biopharma Llc Composicion yodofora novedosa y metodos de uso.
US10265433B2 (en) 2015-03-18 2019-04-23 Lawrence Livermore National Security, Llc Hemorrhage management system
CA2990627A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
US11622920B2 (en) * 2015-12-03 2023-04-11 Symrise Ag Delivery system for active agents
US11273175B2 (en) * 2017-06-26 2022-03-15 Next Science IP Holdings Pty Ltd Method for treating fibrillar collagenous conditions
CA3190833A1 (en) * 2020-08-26 2022-03-03 Michael Mcdonald CROWLEY Compositions, devices and methods for treating nasal, otic and other tissue infection and/or inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966090A (en) * 1969-02-17 1976-06-29 Dart Industries Inc. Package for dispensing an antiseptic composition
US3687855A (en) * 1969-05-05 1972-08-29 Synergistics Inc Solid iodophor cleansing compositions
US4497823A (en) * 1982-11-05 1985-02-05 Moore William T Therapeutic method to reduce pain and inflammation
US5038769A (en) * 1983-06-29 1991-08-13 Krauser Robert S Method and apparatus for treating ailments
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins
FR2714602B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
US20030007939A1 (en) * 1998-07-31 2003-01-09 Howard Murad Pharmaceutical compositions and methods for managing dermatological conditions
IL146132A0 (en) * 1999-05-27 2002-07-25 Euro Celtique Sa Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments
US6495158B1 (en) * 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
EP1449520A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-Iodine liposomes for treatment of herpes

Also Published As

Publication number Publication date
US20120294933A1 (en) 2012-11-22
JP2006518720A (ja) 2006-08-17
EP1449533A1 (en) 2004-08-25
WO2004073720A1 (en) 2004-09-02
US20060292244A1 (en) 2006-12-28
EP1596876B1 (en) 2013-04-10
AR044201A1 (es) 2005-09-07
CY1113959T1 (el) 2016-07-27
DK1596876T3 (da) 2013-05-06
PT1596876E (pt) 2013-05-21
EP1596876A1 (en) 2005-11-23
SI1596876T1 (sl) 2013-07-31
ES2406455T3 (es) 2013-06-07

Similar Documents

Publication Publication Date Title
AU2003216485A1 (en) Process for antimicrobial treatment of fresh produce, particularly mushrooms
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
IL173062A0 (en) Substituted 2-aminotetralin for the treatment of depression
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
YU91002A (sh) Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
IL173377A0 (en) Compounds for the treatment of metabolic disorders
CY1113959T1 (el) Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
EP1594885B8 (de) Medikament zur wachstumsinhibierung von tumoren
TW200509987A (en) Use of PVP-iodine liposomes for treatment of Herpes
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
TW200503778A (en) Use of PVP-iodine liposomes for treatment of atopic dermatitis
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2005047278A3 (de) Substituierte dihydrochinazoline ii
AU2003286118A1 (en) Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
MXPA05012605A (es) Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes.
AU2003289871A1 (en) 2-mercapto-substituted triazolopyrimidines, methods for the production thereof, the use of the same for controlling pathogenic fungi, and agents containing said compounds
AU2003298117A1 (en) 2-substituted triazolopyrimidines, methods and intermediate products for the production thereof, the use of the same for controlling pathogenic fungi, and agents containing said compounds